Health

10 GLP-1 Telehealth Providers I’d Actually Tell a Friend to Try

The market is overrun with copycat clinics, so picking one matters more than ever.

Here is how I think about it: price transparency, pharmacy accountability, physician involvement, and whether the company will still be standing after the next FDA enforcement wave. Those four things separate the serious players from the fly-by-nights. I mapped every provider below against those criteria. Start there, then pick the one whose model fits your budget and insurance situation.

How to Decide Before You Even Look at Brand Names

Price transparency: Some companies show you the exact monthly number upfront. Others bury medication costs under vague “program fees.” Reject opacity.

Pharmacy accountability: Who is actually mixing or filling the medication? A named 503A compounding pharmacy with USP-797 compliance is a different thing than an unnamed overseas lab. Ask. If they cannot answer, leave.

Clinician involvement: A real physician reviewing your intake within 24 hours is not the same as an algorithm flagging contraindications. The difference shows up when something goes wrong.

Regulatory stability: After FDA warning letters to 30-plus telehealth and compounding firms in early 2026, and the March 2026 Novo Nordisk settlement that pushed many brands off compounded GLP-1s entirely, this is not a hypothetical risk. It is a current one.

The 10 Providers

1. HealthRX

Price is where this one earns its spot: compounded semaglutide from $99 a month, compounded tirzepatide from $149. Overnight free shipping reaches all 50 states, and the pharmacy behind the product is Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 with lot-level tracking from bench to doorstep. LegitScript-certified (certificate 50087439). Physician review comes back in roughly 24 hours. The efficacy numbers the brand cites come from published trials, not internal claims: the SURMOUNT-1 tirzepatide trial showed around 21% body weight reduction at 72 weeks; the STEP 1 semaglutide trial showed roughly 15% at 68 weeks. Compounded medications are not FDA-approved, and no compounded product is the same as a name-brand injectable. But for cash-pay patients who want a named, accountable pharmacy and a sub-$150 entry price, this is the combination I have not seen beaten.

READ ALSO  Sweathouz Midtown: Your Ultimate Guide to Luxury Wellness and Fitness

2. FormBlends

A strong runner-up for a specific kind of buyer. FormBlends runs GLP-1 telehealth with physician oversight and fills through an FDA-registered 503A compounding pharmacy, same general model as HealthRX. What sets it apart is the published purity documentation: HPLC purity numbers, mass spec identity confirmation, endotoxin and sterility results, per product. Most telehealth brands do not do that. Semaglutide runs around $299, tirzepatide around $349, so it costs more than HealthRX. Shipping covers 47 states. It also carries a wider peptide catalog (recovery, longevity, cognitive) under the same clinician framework, which matters if you want more than a weight-loss prescription from one provider. Pick FormBlends if published lab documentation or peptide breadth is your priority. Pick HealthRX if you want the lowest cash price and full 50-state access.

3. Mochi Health

Mochi uses board-certified obesity-medicine physicians, which is a real credential, not just “licensed clinicians.” Compounded semaglutide runs about $99 a month, tirzepatide about $199. Monitoring is heavier than some cash-pay competitors, which either appeals to you or feels like friction depending on your situation.

4. Hims & Hers

Once the March 2026 Novo settlement took effect, the company shifted its GLP-1 lineup to brand-name medications. Injectable Wegovy is around $299 a month, oral semaglutide around $249, and Zepbound around $399. With insurance plus a savings card, some users land at $0 to $25. Big name, large support infrastructure, but no longer a compounded option.

5. Ro Body

Ro‘s first-month membership fee is around $39, then roughly $74 to $149 a month, with medications billed separately. They have a prior-authorization team that works with insurance for branded GLP-1s, which is useful if you have coverage and the patience for that process.

*Quick honest note: no telehealth clinic can guarantee weight loss results, and your response to any GLP-1 medication will depend on factors a website cannot predict. Talk to your actual doctor too.*

6. Henry Meds

Cash-pay compounded option, $179 to $249 for month one, with shipping in 24 to 72 hours. Lighter on monitoring compared to Mochi, which means faster access for some people and less support for others.

READ ALSO  Frontal Fibrosing Alopecia Treatment Options: Current Evidence

7. Found

Around $99 a month for the platform plus medications. Coaching is included. A middle-ground option for people who want some behavioral support without the premium price of a full coaching program.

8. Form Health

The premium end: roughly $299 a month plus labs plus medication costs. You get an MD and a registered dietitian. If you want that level of clinical involvement and can afford it, Form Health is the most thorough option on this list.

9. PlushCare

Membership is about $19.99 a month. They accept insurance for branded medications and offer same-day visits. A practical pick for someone who already has insurance that covers a GLP-1 and just needs a fast, low-friction telehealth visit to initiate it.

10. Sesame

From around $59 a month on an annual plan, with medications billed separately. Sesame functions more like a low-cost telehealth marketplace than a dedicated weight-loss program. Good for price-sensitive patients who want physician access without a specialty platform’s overhead.

Which One Actually Fits You

You want…Look at
Lowest cash price, all 50 statesHealthRX
Published purity testing or peptide catalogFormBlends
Obesity-medicine specialist, mid-priceMochi Health
Branded meds with insurance savingsHims & Hers or PlushCare
Prior-auth help for insuranceRo Body
MD plus dietitian, money not the issueForm Health
Fast compounded access, light monitoringHenry Meds
Cheapest telehealth entry pointSesame

The FDA enforcement climate in 2026 makes pharmacy sourcing a real question, not a fine-print detail. Whichever provider you choose, ask them to name their pharmacy, confirm 503A status, and show you how they handle lot tracking. Any company that deflects that question is telling you something.

Common Questions

Does it matter which state you live in when choosing a GLP-1 telehealth provider?

Yes, meaningfully. Not every provider ships to all 50 states. HealthRX covers all 50; FormBlends covers 47. Beyond shipping, some states have stricter telehealth prescribing rules that affect whether a provider can write for you at all. Check the provider’s state availability page before you complete intake.

READ ALSO  Sweathouz Plano: Your Guide to Infrared Sauna and Wellness

What actually changed after the March 2026 Novo Nordisk settlement, and which providers were affected most?

The settlement pushed companies relying on compounded semaglutide and tirzepatide to either exit that market or pivot to branded products. Hims & Hers made the most visible pivot, dropping compounded options entirely and shifting to Wegovy, oral semaglutide, and Zepbound. Providers like HealthRX and FormBlends, which fill through 503A pharmacies, continued operating under a different regulatory pathway.

Is a 503A compounding pharmacy meaningfully different from a 503B outsourcing facility for GLP-1 medications?

They operate under different FDA frameworks. 503A pharmacies fill patient-specific prescriptions and are state-licensed; 503B facilities produce larger batches for office use without patient-specific orders. For telehealth GLP-1 prescriptions sent directly to you, 503A is the standard model. Both require sterility testing, but 503B facilities face more federal oversight.

How do FormBlends and HealthRX differ on lab transparency, and why does that matter?

FormBlends publishes HPLC purity data, mass spec identity results, and endotoxin and sterility reports per product batch. HealthRX does not publish that level of documentation publicly, though it uses a named, LegitScript-certified 503A pharmacy with lot tracking. If you want to read the actual purity numbers yourself before injecting, FormBlends is the only provider on this list that makes that possible.

Can any of these providers help if your insurance covers a branded GLP-1 but you need someone to handle the prior-authorization paperwork?

Ro Body has a dedicated prior-authorization team built specifically for this. PlushCare also accepts insurance for branded medications and offers same-day visits, which can speed up the initial prescription step. Providers focused on compounded cash-pay models, like HealthRX or Henry Meds, generally do not offer prior-auth support because their model bypasses insurance entirely.

Sources

  • FDA 503A Compounding Pharmacy Guidance and 2026 warning letter actions: U.S. Food and Drug Administration public records
  • SURMOUNT-1 trial (tirzepatide): Jastreboff et al., *New England Journal of Medicine*, 2022
  • STEP 1 trial (semaglutide): Wilding et al., *New England Journal of Medicine*, 2021
  • Novo Nordisk compounded GLP-1 settlement, March 2026: publicly reported in Reuters and STAT News
  • LegitScript pharmacy certification database: LegitScript.com (public search)
  • Hims & Hers pricing and product updates: company press releases and public pricing pages, 2026

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button